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New & Noteworthy 42 
We report for the first time that post-exercise cold-water immersion of one limb also 43 
enhances PGC-1α expression in a contra-lateral non-immersed limb.  We suggest increased 44 
systemic β-adrenergic stimulation, and not localised cooling per se, exerts regulatory effects 45 
on local signalling cascades thereby modulating PGC-1α expression. These data therefore 46 
have important implications for research designs that adopt contralateral non-immersed limbs 47 
as a control condition, whilst also increasing our understanding of potential mechanisms 48 
underpinning cold-mediated PGC-1α responses. 49 
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Abstract 63 
Mechanisms mediating post-exercise cold-induced increases in PGC-1α gene expression in 64 
human skeletal muscle are yet to be fully elucidated, but may involve local cooling effects on 65 
AMPK and p38 MAPK related signalling and/or increased systemic β-adrenergic stimulation. 66 
We aimed to therefore examine whether post-exercise cold-water immersion enhancement of 67 
PGC-1α mRNA is mediated through local or systemic mechanisms. Ten subjects completed 68 
acute cycling (8x5 min at ~80% peak power output) followed by seated-rest (CON) or single-69 
leg cold-water immersion (CWI; 10 min, 8°C). Muscle biopsies were obtained pre-, post- and 70 
3 h post-exercise from a single limb in the CON condition but from both limbs in CWI 71 
(thereby providing tissue from a CWI and non-immersed limb, NOT).  Muscle temperature 72 
decreased up to 2 h post-exercise following CWI (-5°C) in the immersed limb, with lesser 73 
changes observed in CON and NOT (-3°C; P<0.05). No differences between limbs were 74 
observed in p38MAPK phosphorylation at any time point (P<0.05), whilst a significant 75 
interaction effect was present for AMPK phosphorylation (P=0.031). Exercise (CON) 76 
increased gene expression of PGC-1α 3 h post-exercise (~5-fold; P<0.001). CWI augmented 77 
PGC-1α expression above CON in both the immersed (CWI; ~9-fold; P=0.003) and NOT 78 
limbs (~12-fold; P=0.001). Plasma Normetanephrine concentration was higher in CWI vs. 79 
CON immediately post-immersion (860 vs. 665 pmol/L; P=0.034). We report for the first 80 
time that local cooling of the immersed limb evokes transcriptional control of PGC1-α in the 81 
non-immersed limb, suggesting increased systemic β-adrenergic activation of AMPK may 82 
mediate, in part, post-exercise cold-induction of PGC-1α mRNA. 83 
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Introduction 87 
It is well established that the transcriptional co-activator peroxisome proliferator-activated 88 
receptor γ coactivator-1α (PGC-1α), the proposed “master regulator” of skeletal muscle 89 
mitochondrial biogenesis (37), is sensitively controlled by acute and chronic exercise (3, 4, 90 
10, 36). Upstream control of PGC-1α includes phosphorylation by energy and stress sensing 91 
kinases AMP-activated protein kinase (AMPK) (23) and p38 mitogen-activated protein 92 
kinase (p38 MAPK) (2).  Consistent with its initial discovery as cold-inducible (34, 38), 93 
recent studies have examined the potential of acute post-exercise cold exposure to also 94 
modulate PGC-1α expression. For example, in human tissue, both cold-ambient temperatures 95 
(42, 43) and post exercise cold-water immersion (18, 20) enhances the skeletal muscle PGC-96 
1α gene transcription and protein translational response versus exercise alone. The precise 97 
mechanism(s) mediating cold-induced regulation of the PGC-1α transcriptional pathway have 98 
yet to be fully determined, though the cooling-induced alterations in muscle blood flow (14, 99 
30) are unlikely to mediate these effects (33, 45).  It is noteworthy, however, that chronic 100 
cold-induced changes in PGC-1α protein content arise in conjunction with increased activity 101 
of signalling kinases AMPK and p38 MAPK (18).  These data suggest that cooling of the 102 
skeletal muscle tissue may play a role in mediating the post-exercise cold-induction of PGC-103 
1α mRNA through activation of local signalling kinases.   104 
Alternatively, systemic control via increased β-adrenergic activity is suggested to play a 105 
potent role in mediating the effects of cold exposure on PGC-1α expression via AMPK (29) 106 
and β2-adrenergic receptor (31) mechanisms.  Indeed, plasma norepinephrine concentrations 107 
remain higher following high-intensity exercise after cold-water immersion versus control 108 
conditions (13).  Studies to date have utilised the non-immersed limb as the control condition 109 
without the use of a true control (no cooling) condition (11, 18, 20). By assuming the 110 
response to cold-water immersion is mediated locally, such experimental designs do not 111 
permit examination of the role of systemic versus localised mechanisms in mediating cold-112 
induced changes in PGC-1α. Indeed, Ihsan et al. (20) observed that PGC-1α gene 113 
transcription was not induced in a non-immersed control limb, despite the limb having 114 
previously been exercised, and exercise being a potent stimulus to induce PGC-1α 115 
expression. This would therefore suggest that an induction of PGC-1α expression in an 116 
immersed limb occurred by way of cold-induced mechanisms. In this regard, we suggest that 117 
the increased systemic β-adrenergic activity associated with post-exercise cooling of the 118 
immersed limb could also modulate PGC-1α expression in the non-immersed contralateral 119 
limb.  120 
Therefore, the aim of the present study was to examine whether the cold-water induced 121 
increase in PGC-1α mRNA observed post exercise is mediated through local or systemic 122 
mechanisms.  To this end, we employed a novel experimental design (in a repeated measures 123 
crossover design) where ten recreationally active males completed an acute cycling protocol 124 
(8x5 min at ~80% peak power output) followed by a seated-rest condition (CON) or single-125 
leg cold-water immersion (CWI; 10 min, 8°C). Muscle biopsies were obtained pre-, post- and 126 
3 h post-exercise from a single limb in the CON condition but from both limbs post-exercise 127 
in the CWI trial (thereby providing tissue from a CWI and non-immersed limb, NOT).  In this 128 
way, our design allowed us to obtain tissue from true control conditions but yet, also sample 129 
tissue from an immersed and non-immersed limb that was subject to the same hormonal 130 
milieu. 131 
 132 
Methods 133 
Subjects. Ten recreationally active healthy males (age 26 ± 4 y; body mass 79.29 ± 6.73 kg; 134 
height 180 ± 5 cm; V̇O2peak 51.46 ± 9.07 mL.kg-1.min-1; peak power output (PPO) 265.2 ± 135 
38.33 W; mean ± SD) participated in this study. Subjects were instructed to refrain from 136 
exercise, alcohol and caffeine 48 hours prior to the test day. All subjects gave written 137 
informed consent to participate after details and procedures of the study had been fully 138 
explained. Subjects had no history of neurological disease or musculoskeletal abnormality 139 
and none were under any pharmacological treatment during the course of the study. Each 140 
subject was medically screened by a practising GP prior to participation for their individual 141 
risk associated with high-intensity exercise, muscle biopsy procedures and immersion in cold 142 
water. All procedures performed in the study were approved by the Ethics Committee of 143 
Liverpool John Moores University and in accordance with the 1964 Helsinki declaration and 144 
its later amendments. 145 
Experimental Design. In a repeated-measures crossover design, subjects completed two high-146 
intensity intermittent cycling protocols followed either by 10 min seated rest (CON) or 147 
single-leg CWI (10 min at 8°C). Muscle biopsies were obtained from the vastus lateralis 148 
immediately before, post- and 3 h post-exercise. During the CWI trial muscle biopsies in the 149 
post-exercise period were taken from both the immersed and non-immersed leg. This design 150 
allowed us to assess the impact of the cold stimulus locally (immersed leg) and systemically 151 
(non-immersed leg) against a relevant resting control. Both experimental trials were 152 
conducted in a counterbalanced, randomized order with at least 10 days between conditions.  153 
Experimental Protocol.  Subjects attended the laboratory on 3 separate occasions. On the first 154 
occasion, subjects completed an incremental exercise test to fatigue for the determination of 155 
V̇O2max and PPO (15). Results from this test were used to determine the power output 156 
necessary for cycling at a proportion of PPO on subsequent test days (detailed below). Prior 157 
to the first test day, subjects completed a 24-hour food diary to be replicated before the 158 
second trial. Upon arrival at the laboratory (0900h) subjects were fitted with a heart-rate 159 
monitor (Polar RS400, Kempele, Finland), skin and rectal temperature probes (MHF-18050-160 
A and MRV-55044-A, Ellab, Rodovre, Denmark). Legs were marked for subsequent 161 
insertion of muscle temperature needles; area of insertion was calculated as half the length of 162 
the femur, over the ‘belly’ of the vastus lateralis. The needle thermistor was then placed at a 163 
depth of 3cm, plus one-half of the skinfold measurement, for the determination of deep 164 
muscle temperature (3cm). Following 10-min resting in a supine position, baseline measures 165 
of heart rate (HR), temperature and oxygen uptake (V̇O2; Oxycon Pro, Jaeger, Wuerzberg, 166 
Germany) were assessed. Resting venous blood samples were drawn from a superficial vein 167 
in the anti-cubital crease of the forearm using venepuncture cannulation (BD Nexiva Closed 168 
IV Catheter 22G Blue, Becton Dickinson, Oxford, UK). Resting muscle temperature was 169 
assessed using a needle thermistor (13050; Ellab, Rodovre, Denmark) inserted into the vastus 170 
lateralis at 3cm depth as previously described (30).  Finally, resting muscle biopsy samples 171 
from the vastus lateralis (~30–50 mg wet wt) were obtained under local anaesthesia (0.5% 172 
marcaine) using a Pro-Mag 2.2 biopsy gun (MD-TECH, Manan Medical Products, 173 
Northbrook, IL). At rest only a single leg was biopsied in the cooling trial (CWI) in attempt 174 
to reduce the stress experienced by subjects. This leg was randomised between the immersed 175 
and non-immersed limbs to exclude potential variation caused by leg dominance; all 176 
subsequent biopsies were completed in both legs, at each time point, 2cm proximal to the 177 
previous incision. 178 
Following the resting biopsy, subjects completed a high-intensity intermittent cycling 179 
protocol consisting of 8 × 5min bouts at 82.5% PPO separated by 1 min rest (adapted from 180 
44) followed by either single-legged CWI (CWI: 10 min at 8°C; NOT: non-immersed leg i.e. 181 
10 min at room temperature) or a control condition (CON; seated rest). CWI was conducted 182 
using a specialised seated mechanical hoist to lower the subject so that one leg was placed 183 
inside the cold-bath, allowing the other (NOT) to remain outside, and dry. Subjects then 184 
recovered in a semi-reclined position under normal laboratory temperatures (~21°C) until 3-185 
hours post-exercise. Measures of heart rate, skin temperature (thigh and calf) and rectal 186 
temperature were recorded throughout the exercise and recovery periods. Oxygen uptake was 187 
measured during the final minute of each high-intensity bout of exercise, during immersion, 188 
immediately post-immersion and again at 1, 2 and 3 h post-exercise. Ratings of perceived 189 
exertion (RPE) were assessed during the final minute of each exercise bout (5), whilst 190 
subjective measures of perceived shivering were assessed throughout water immersion and 191 
the 3h recovery period using a visual analogue scale from 1 (No shivering) to 5 (Intense 192 
Shivering) (24). Laboratory temperatures remained stable throughout (21.18 ± 0.76oC) and at 193 
no point were subjects allowed to rub themselves dry or shower (changing into dry shorts 194 
after immersion was allowed). Subjects were advised to wear the same clothes between trials. 195 
Muscle temperature was assessed post-exercise, immediately post-immersion and at 1, 2 and 196 
3h post-exercise. Venous blood samples were also drawn at these times. Bi-lateral muscle 197 
biopsies occurred immediately after exercise and 3h post-exercise.  198 
Venous blood samples were drawn from a superficial vein in the anti-cubital crease of the 199 
forearm using standard venepuncture techniques (BD Nexiva Closed IV Catheter 22G Blue, 200 
Becton Dickinson, Oxford, UK). Blood samples (~10ml) were collected into vacutainer tubes 201 
(Becton Dickinson, Oxford, UK) containing EDTA and stored on ice until centrifugation at 202 
1500 rev.min-1 for 15-min at 4oC. Following centrifugation, aliquots of plasma were stored at 203 
-80oC for later analysis. Plasma metanephrine and Normetanephrine concentrations were 204 
measured using liquid chromatography tandem mass spectrometry as previously described 205 
(35). All samples were analysed in duplicate, with the mean value employed.  206 
rt-qRT-PCR. Skeletal muscle samples (~30 mg) were transferred to 2 ml lysing tubes 207 
containing 1.4 mm ceramic beads (Lysing Matrix D, MP Biomedicals, UK) containing 1 ml 208 
ice-cooled TRI- reagent (Life Technologies Ltd, UK) and homogenised at 6 m/s for 3 x 40 209 
seconds, separated by 5 minutes cooling on ice (MP Fastprep-24, MP Biomedicals, UK). 210 
RNA was extracted according to the TRI-reagent manufacturer’s instructions. RNA 211 
concentration and purity were assessed by UV spectroscopy at ODs of 260 and 280 nm using 212 
a Nanodrop 3000 (Fisher, Rosklide, Denmark). A target of A260 / A280 ratio was set at 1.8 to 213 
2.2. Seventy ng RNA was used for each PCR reaction. Primer sequences (Table 1) were 214 
identified using Gene (NCBI, http://www.ncbi.nlm.nih.gov.gene) and designed using Primer-215 
BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Sequence homology 216 
searches ensured specificity and that all primers had no potential unintended targets. The 217 
primers were ideally designed to yield products spanning exon-exon boundaries to prevent 218 
any amplification of gDNA. Three or more GC bases in the last five bases at the 3’ end of the 219 
primer were avoided. Secondary structure interactions (hairpins, self-dimer and cross dimer) 220 
within the primer were avoided. All primers were between 16 and 25 bp, and amplified a 221 
product of between 67-212 bp. Primers were purchased from Sigma (Suffolk, UK). 222 
rt-qRT-PCR amplifications were performed using QuantiFastTM SYBR® Green RT-PCR one 223 
step kit on a Rotor-gene 3000Q (Qiagen, Crawley, UK) supported by rotor-gene software 224 
(Hercules, CA, USA). rt-qTR-PCR was performed as follows: hold 50°C for 10 min (reverse 225 
transcription/cDNA synthesis), 95°C for 5 min (transcriptase inactivation and initial 226 
denaturation step) and PCR steps of 40 cycles; 95°C for 10s (denaturation), 60°C for 30s 227 
(annealing and extension). Upon completion, dissociation/melting curve analysis were 228 
performed to reveal and exclude non-specific amplification or primer-dimer issues (all melt 229 
analysis in this study presented single reproducible peaks for the reference gene and each 230 
target gene suggesting amplification of a single product). Following initial screening of 231 
suitable reference genes, GAPDH showed the most stable Ct values across all RT-PCR runs, 232 
subjects and regardless of experimental condition (23.54 ± 1.69 Ct; 7% Co-efficient of 233 
variation) and was selected as the reference gene in all RT-PCR assays. The average PCR 234 
efficiency was 90% and variation for all genes was less than 4.3%. The relative gene 235 
expression levels were calculated using the comparative Ct (ΔΔCt) equation (41) where the 236 
relative expression was calculated as 2-ΔΔct and where Ct represents the threshold cycle. 237 
mRNA expression for all target genes was calculated relative to the reference gene (GAPDH; 238 
subject’s own samples reference) within same subject and condition and to a calibrator of 239 
Pre-exercise. 240 
SDS-PAGE and Western Blotting. Approximately 30 mg of frozen muscle was homogenized 241 
using 2.4 mm ceramic beaded tubes (6 m/s for 3 x 40 seconds, separated by 5 minutes 242 
cooling on ice; MP Fastprep-24, MP Biomedicals, UK), in 500 µl of ice-cold lysis buffer [25 243 
mM Tris·HCl (pH 7.4), 50 mM NaF, 100 mM NaCl, 5 mM EGTA, 1 mM EDTA, 10 mM 244 
Na-pyrophosphatase, 1% Triton X-100] and supplemented with a protease phosphatase 245 
inhibitor cocktail (Halt Protease and Phosphatase Inhibitor 186 Cocktail, Thermo Scientific, # 246 
78442). The resulting homogenates were centrifuged at 14,000 g for 10 min at 4°C, and the 247 
supernatant was collected. The protein content of the supernatant was determined using a 248 
bicinchoninic acid assay (Sigma, UK). Each sample was diluted with an equal volume of 2X 249 
Laemmli buffer (National Diagnostics) and boiled for 10 min at 100°C. Forty µg of total 250 
protein from each sample was loaded (65 µg for phosphorylated analyates) and then 251 
separated in Tris-glycine running buffer (10x Tris/glycine, Geneflow, Staffordshire, UK) 252 
using self-cast 10% separating [33% Protogel; (30% w/v acrylamide: 0.8% (w/v) Bis-253 
Acrylamide stock solution (37.5:1)), 25% Protogel resolving buffer (1.5M Tis-HCL, 0.4% 254 
SDS, pH 8.8), 41% ddH2O, 100µl 10% APS, 20µl TEMED] and 4% stacking [13% Protogel, 255 
25% Protogel Stacking buffer (0.5M Tris HCL, 0.4% SDS, pH 6.8), 61% ddH2O, 100µl 10% 256 
APS, 20µl TEMED] gels (National Diagnostics, Geneflow, UK). Gels were transferred 257 
semidry onto nitrocellulose membrane (Transblot Turbo, BioRad) for 30 min at 25V and 1.0 258 
mA in transfer buffer [10% TRIS/glycine (Sigma), 20% methanol, 70% ddH2O). After 259 
transfer, membranes were briefly washed in TBST (0.19 M Tris pH 7.6, 1.3 M NaCl, 0.1% 260 
Tween-20] before being blocked for 1 h at room temperature in TBST with 1% BSA. The 261 
membranes were then washed for 3 x 5 min in TBST before being incubated overnight at 4°C 262 
with antibodies for anti-phospho-AMPK Thr172 (cat no: 2532), p38 MAPKThr180/Tyr182 263 
(cat no: 9211) (Cell Signalling) as well as total protein content of AMPK (cat no: 2531), p38 264 
MAPK (cat no: 9212) (Cell Signalling, UK), GAPDH (25778; Santa Cruz), and PGC-1α 265 
(Calbiochem, Merck Chemicals, UK) all at concentrations of 1:1000 in 1 x TBS. The 266 
following morning, membranes were washed for a further 3 x 5 min in TBST and 267 
subsequently incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary 268 
antibody (Bio-Rad, UK) for 1h at room temperature. After a further 3 x 5 min washes in 269 
TBST, membranes were exposed in a chemiluminescence liquid (SuperSignal, Thermo Fisher 270 
Scientific, Rockford, IL) for 5 min (30 sec for GAPDH). Membranes were visualized using a 271 
Bio-Rad Chemi-doc system, and band densities were determined using Image Lab image-272 
analysis software (Bio Rad, UK). Samples from each subject for all exercise conditions were 273 
run on the same gel and statistical analysis conducted on raw densitometry data. 274 
Phosphorylated AMPK Thr172 and p38 MAPK Thr180/Tyr182 were normalised to their total 275 
protein, as these did not change significantly across blots or samples (P > 0.05). PGC-1α was 276 
normalised to GAPDH.  277 
Statistical analysis. All data are presented as mean ± SD, unless otherwise stated. Baseline 278 
data, distance cycled, exercise HR and RPE were compared between conditions using a 279 
Paired Samples T-test. A two-factor (two condition × time) within-participants general linear 280 
model was used to evaluate the effect of time (baseline v post exercise) with shared baseline 281 
data used for NOT and CWI (Statistical Package for the Social Sciences version 21.0; SPSS 282 
Inc., Chicago, IL). A two-factor (three condition × time) within-participants general linear 283 
model was subsequently used to evaluate the influence of the cooling intervention following 284 
exercise and the 3h post exercise period. The main effects for condition and time was 285 
followed up using planned LSD multiple contrasts.  Where a significant condition by time 286 
interaction was observed, the post exercise to 3h post exercise change scores were calculated 287 
and compared across the 3-conditions using LSD multiple contrasts. The ES magnitude was 288 
classified as trivial (<0.2), small (>0.2-0.6), moderate (>0.6-1.2), large (>1.2-2.0) and very 289 
large (>2.0-4.0) (17). The α level for evaluation of statistical significance was set at P < .05.  290 
 291 
 292 
Results 293 
Exercise Response.  294 
Distance cycled (CON 32.52 ± 4.21 km, CWI 32.33 ± 4.33 km; P = 0.629, ES 0.04 Trivial), 295 
heart rate (P = 0.309, ES 0.13 Trivial), V̇O2 (ml/kg.min-1; P = 0.855, ES 0.02 Trivial) and 296 
RPE (P = 0.637, ES 0.08 Trivial) were similar between CON and CWI trials (data not 297 
shown). Mean HR during the final minute of exercise was 182 ± 8 beats.min-1 in CON and 298 
183 ± 8 beats.min-1 in CWI, equating to ~94% HR max. The RPE in the final exercise bout 299 
was 19 ± 1 AU and 19 ± 1 AU in the CON and CWI trials respectively.  300 
 301 
Recovery Response. 302 
Metabolic Responses. Heart rate (ES 0.90 Moderate) and V̇O2, (ES 1.20 Moderate) was 303 
higher in CWI vs CON during the post-exercise recovery period (Table 2; P < 0.001).  The 304 
change in HR and V̇O2, over time was also different between conditions (P <0.001) with 305 
increases in HR and V̇O2, occurring during the initial 2 minutes of immersion.  Following 306 
immersion, HR and V̇O2 dropped below pre-immersion values and remained lower 307 
throughout the 3h recovery period (HR, ES >0.92 Moderate; V̇O2, ES >1.25 Large) (P < 308 
0.05). 309 
Thermoregulatory Responses. Rectal temperature was similar between conditions throughout 310 
the post-exercise period (CON 37.52 ± 0.24°C, CWI 37.48 ± 0.05°C, ES 0.49 Small, P = 311 
0.217. The change in rectal temperature over time was different between conditions, with a 312 
small decline in rectal temperature occurring after 3 minutes of immersion until 3h post-313 
exercise (P=0.034, ES >0.22 Small). Thigh skin temperature was generally lower throughout 314 
the post-exercise recovery period in CWI versus CON (ES 6.26 Very Large) and NOT (ES 315 
6.46 Very Large) (Figure 1a, P < 0.001). The change over time was also different between 316 
conditions, with thigh skin temperature continually decreasing in CWI and remaining lower 317 
than pre-immersion values until 1h post exercise (ES 3.0 Very Large, P < 0.001).  Values in 318 
CON and NOT limbs remained similar to pre-immersion throughout the 3h recovery period 319 
(P = 0.10, ES 0.57 Small). 320 
Post-exercise muscle temperature (3 cm depth) was similar between CON (38.75°C), CWI 321 
(38.86°C) and NOT (38.54°C) (Figure 1b; P > 0.05). During the 3 h recovery period muscle 322 
temperature (3cm) was lower in CWI versus CON (ES 1.60 Large) and NOT (ES 1.77 Large) 323 
(P < 0.001). The change in muscle temperature over time was also different between 324 
conditions (P < 0.001).  Muscle temperature declined to a large extent immediately after 325 
immersion in the CWI limb, followed by a further gradual reduction during the remaining 3h 326 
post-exercise period (P < 0.001).  In CON and NOT conditions, muscle temperature was 327 
reduced to a lesser extent immediately following immersion followed by a further gradual 328 
reduction during the 3h post-exercise period (P = 0.246, ES 0.34 Small) (See Figure 1b).  329 
Subjective shivering ratings were greater in CWI vs CON during the post-exercise recovery 330 
period (ES 1.20 Large, P = 0.067). The change in shivering over time also tended to be 331 
different between conditions (P = 0.062), with ‘slight’ shivering observed in the CWI 332 
condition during the first 2 minutes following immersion (ES >0.60 Moderate). Slight 333 
shivering was also observed 2h post exercise in the CWI condition (ES 0.95 Moderate). 334 
AMPK and P38 MAPK activity and total abundance 335 
Phosphorylation of AMPK Thr172 was not increased post-exercise (P = 0.242, ES 0.20 Small). 336 
At post-exercise and 3h post-exercise phosphorylation of AMPKThr172 was similar between 337 
conditions (P = 0.846, ES 0.03 Trivial).  However, the change in AMPKThr172 between these 338 
time points was different between conditions (P = 0.031; Figure 2). AMPKThr172 339 
phosphorylation increased in CWI vs. CON (P = 0.027, ES 1.22 Large) with a moderate 340 
increase in AMPKThr172 phosphorylation also observed in NOT vs. CON (P = 0.145, ES 0.70 341 
Moderate). Representative Western blots are shown in Figure 5. 342 
Exercise induced a small increase in phosphorylation of p38MAPKThr180/Tyr182 (P = 0.056, ES 343 
0.44 Small, Figure 3). At post exercise and 3h post-exercise phosphorylation of 344 
p38MAPKThr180/Tyr182 was similar between conditions (P = 0.672; ES 0.03, Trivial). No 345 
differences in the change in phosphorylation between these time points was observed 346 
between conditions (P = 0.268, Figure 3). Representative Western blots are shown in Figure 347 
5.  348 
PGC-1alpha mRNA and protein abundance.  349 
PGC-1α mRNA expression was moderately increased with exercise (P = 0.066, ES 0.92 350 
Moderate, Figure 4a). At 3h post-exercise, expression was greater in CWI (ES 1.2 Moderate, 351 
P = 0.003) and NOT (ES 1.6 Large, P = 0.001) versus CON, but was similar between CWI 352 
and NOT (ES 0.6 Small, P = 0.141) (Figure 4a). This reflected the greater change in 353 
expression in CWI and NOT conditions between post exercise and 3h post exercise time 354 
points (P = 0.001, Figure 4a). PGC-1α protein content was not influenced by exercise (P = 355 
0.092) or CWI (P = 0.471, Figure 4b). Representative Western blots are shown in Figure 5. 356 
Additional gene expression 357 
Exercise induced increases in SIRT1 (P = 0.057, ES 0.8 Moderate) and NRF2 (P = 0.028, ES 358 
0.6 Moderate) mRNA (data not shown). No changes were seen between conditions, or 359 
between conditions over time (P > 0.05). Gene expression analysis for p53, COXIV, CS, 360 
TFAM, SIRT1, NRF2 and ERRα mRNA was not influenced by exercise or CWI (P > 0.05; 361 
data not shown). 362 
 363 
Plasma Metanephrine and NorMetanephrine.   364 
Metanephrine concentrations were similar between conditions (P = 0.159, ES 0.15 Trivial). 365 
The change in metanephrine over time was also similar between conditions (P = 0.299). 366 
Metanephrine concentration was increased post-exercise (ES 2.46 Very Large) and post-367 
immersion (ES 0.77 Moderate) vs. baseline (P ≤ 0.02). Normetanephrine values were greater 368 
in CWI vs. CON (P = 0.034, ES 0.43 Small) with the largest difference seen post-immersion 369 
(860 vs. 665 pmol/L, CWI vs. CON, respectively). The change in Normetanephrine over time 370 
was similar between conditions (P = 0.821). Normetanephrine concentrations increased with 371 
exercise (ES >4.70; P < 0.001) and remained above baseline post-immersion (ES 1.52 Large) 372 
and 1hr post-exercise (ES 1.06 Moderate) (P <0.001). Concentrations returned to baseline at 373 
2hr post-exercise (See Table 3).  374 
 375 
Discussion 376 
The aim of the present study was to examine whether the post-exercise cold-water induced 377 
increase of PGC-1α mRNA is mediated through local or systemic mechanisms. Using a novel 378 
experimental design, we report for the first time the appearance of systemic “cross-talk” 379 
between immersed and non-immersed limbs, as evidenced by the similar increase in PGC-1α 380 
mRNA in these limbs after single-legged CWI.  Additionally, we suggest that this effect 381 
could be mediated by β-adrenergic induced stimulation of AMPK.  In addition to providing 382 
novel data on the potential mechanisms mediating post-exercise cold-induced enhancement 383 
of PGC-1α expression, our data also have potential implications for research designs that 384 
utilise as non-immersed limbs as control conditions.  385 
Since its initial discovery (38) the importance of the post-exercise PGC-1α response to the 386 
oxidative adaptive process has been examined extensively, with mRNA increases ranging 5 387 
to 10-fold commonly observed at 3-4 hours following exercise (3, 4, 21, 36).  More recently, 388 
cold-ambient temperatures (42, 43) and post exercise cold-water immersion (18-20, 24), have 389 
also been shown to enhance (~2- to 4- fold greater) the skeletal muscle PGC-1α gene 390 
transcription and protein translational response versus exercise alone. In line with such 391 
observations, the high-intensity intermittent cycling protocol used in the present study elicited 392 
a ~5-fold increase in PGC-1alpha mRNA at 3 hours post-exercise. Furthermore, CWI 393 
enhanced this response to a greater extent than exercise alone (~9-fold increase vs. Pre in the 394 
CWI immersed limb).  395 
There have been suggestions that reduced tissue temperature may be responsible for the 396 
differences observed between cold-treated and control limbs. This stems from the initial 397 
discovery that PGC-1alpha was cold inducible in animals (6, 9, 38).  In humans, recent data 398 
from Ihsan and colleagues (18, 20) implicates a reduction in tissue temperature in the cold-399 
induced increases of PGC-1α, as increases in mRNA (3h post-exercise) and protein content 400 
(after 4 weeks of training) were seen only in a cooled limb, and not in the contralateral non-401 
immersed limb.  Potential mechanisms underpinning such responses include activation of 402 
non-noxious thermoreceptors via reduced skin temperature (Hensel & Boman, 1960, 22). 403 
Within the present study, both the NOT and CWI limbs displayed similar acute PGC-1α 404 
mRNA expression in the 3 h recovery period, whilst skin and muscle temperature were 405 
significantly reduced in the CWI limb only.  Indeed, the non-immersed limb (NOT) showed a 406 
similar temperature profile (skin and muscle temperature) to that of CON, where the 407 
magnitude of PGC-1α mRNA response was almost half when compared with CWI and NOT.  408 
When taken together, these data suggest that alterations to local muscle temperature do not 409 
play a significant role in cold-induced regulation of PGC-1α expression.  410 
As a result of increased local PGC-1α gene expression in the non-immersed exercised limb to 411 
a similar magnitude as the immersed limb, we sought to consolidate the role of the upstream 412 
kinases AMPK and p38-MAPK (7, 23, 47) in their ability to regulate PGC-1α transcription. 413 
p38MAPK is a stress activated kinase that has been shown extensively to be phosphorylated 414 
after acute exercise, independent of intensity (10). Moreover, p38MAPK can exert its effect 415 
upon PGC-1α transcription via upregulated ATF2 activity at the PGC-1α promoter (2). In the 416 
current study, exercise induced a small (ES 0.44, 1.5-fold) increase in phosphorylation with 417 
no further response to cooling.  Moreover, our data supports previous data showing acute 418 
post-exercise phosphorylation of p38MAPK locally in skeletal muscle tissue occurs 419 
systemically (46). Exercise-induced intensity dependant AMPK phosphorylation is a well 420 
reported phenomenon (8, 12, 28) in rodent and human studies (34, 10). Moreover, AMPK is 421 
implicated in PGC-1α activity via direct phosphorylation, initiating many of the important 422 
gene regulatory functions of PGC-1α in skeletal muscle (23). The post-exercise increase in 423 
phosphorylation of AMPK in the present study was similar in magnitude to previous work (3) 424 
from our laboratory, albeit failing to achieve statistical significance. Notwithstanding this, 425 
large and moderate effect sizes were observed at 3 h post-exercise in the CWI and NOT limbs 426 
vs. CON, respectively. These greater increases from post-exercise to 3 h post-exercise in the 427 
immersion trial (CWI and NOT limbs), compared to a slight decline in CON suggest the 428 
increases in phosphorylation of AMPK during the post-cooling period are controlled by a 429 
systemic mechanism, possibly adrenergic control via cold-augmented plasma 430 
Normetanephrine.   431 
Epinerphrine and norepinephrine are both dual α- and β- adrenergic agonists. Previous in 432 
vivo and in vitro incubation techniques utilising α- and β- adrenergic agonists have reported 433 
increased AMPK activation in rodent skeletal muscle (32), adipose tissue (26) and cell 434 
cultures (48) implicating catecholamines as a potential AMPK activator. Despite this, support 435 
for the above hypothesis is currently conflicting, and is limited by distinct differences in 436 
methodological design and species studied. In rodent muscle, acute infusion of adrenergic 437 
agonists/antagonists have previously shown to be ineffective at altering PGC-1α 438 
transcriptional activity (39, 40) and its upstream effector p38-MAPK (25). In contrast, 439 
treatment with β-adrenergic agonists/antagonists has been shown to induce and inhibit PGC-440 
1α respectively (31), whilst incubation of rodent skeletal muscle with the adrenergic agonist 441 
phenylephrine increased the activity of the upstream regulator of PGC-1α, AMPK (32). 442 
When results from these studies are taken together, it could be suggested that adrenergic 443 
activation of AMPK is a potential mechanism to explain the systemic increases in PGC-1α 444 
gene expression described herein.  445 
In humans, one study has investigated the impact of higher catecholamine levels on AMPK 446 
phosphorylation in human skeletal muscle (27). These authors assessed muscle biopsies from 447 
an exercised and non-exercised limb in conditions of heightened catecholamine release. 448 
Results showed AMPK activity was restricted to contracting muscle only, with no systemic 449 
effects notable in the non-exercised limb despite the increased catecholamine levels. 450 
Importantly, in our study all limbs were exercised before undergoing cold exposure. It 451 
therefore may be that the cold induction of β-adrenergic pathways (via increased 452 
catecholamines) presented in this manuscript allows an additive response to exercise 453 
stimulated AMPK phosphorylation. Further studies are now required to verify this signalling 454 
response in related experimental conditions in human skeletal muscle. 455 
Another pathway by which increased catecholamine’s may enhance PGC-1α transcription is 456 
via increased activation of β-adrenergic receptors. Activation of these receptors increases 457 
intracellular cAMP, which could ultimately activate CREB function on the PGC-1α promoter 458 
(1). However, evidence exists to show β-adrenergic stimulation does not activate a 459 
p38MAPK - ATF2 - CREB - PGC-1α signalling axis in skeletal muscle (25). These findings 460 
resonate with results from the present study as no changes in phosphorylation of p38MAPK 461 
were observed alongside increased plasma Normetanephrine concentrations. Further work is 462 
required to investigate the influence of the dual stress of exercise and cold temperature upon 463 
this signalling axis.  464 
Downstream of PGC-1α, Slivka and colleagues (42) noted that recovery in cold ambient 465 
temperatures (4h in 7°C ambient air) reduced the expression of the transcription factors 466 
Nuclear-respiratory factor 2 (NRF2) and estrogen-related receptor α (ERRα), whilst having 467 
no effect on mitochondrial transcription factor a (TFAM). Their importance to the adaptive 468 
response is highlighted by their roles in oxidative metabolism. Our data suggest the 469 
immersion protocol used herein was not sufficient to induce such changes. Indeed, 10 470 
minutes of single-legged immersion offers a much smaller cooling stimulus than the 4 hours 471 
in cool ambient temperatures, as used by Slivka et al. (42). In addition, an acute increase in 472 
PGC-1α gene expression was not followed by changes in PGC-1α total protein content, 473 
perhaps due to the acute time-frame of sampling applied in the present study. With this lack 474 
of change in total protein content it is however, unlikely that changes in gene expression of 475 
downstream genes such as NRF2, TFAM, COXIV, CS, ERRα presented here, would be 476 
affected by its upstream protein function as a transcription factor (PGC-1α). More research is 477 
required to understand the effect and dose response of a cold stimulus on downstream targets 478 
of PGC-1α. 479 
It is difficult to explain the differences in PGC-1alpha mRNA results between the present 480 
study and Ihsan et al. (20), particularly the difference in non-immersed limbs. Moreover, 481 
reasons as to why Ihsan and colleagues failed to see the expected exercise-induced response 482 
in their non-immersed control limb, with minor changes from baseline at 3h post-exercise 483 
(1.5-fold increase vs. 3-5-fold increase usually seen), remain unclear. One possible 484 
explanation might include the differing muscle recruitment patterns occurring between the 485 
exercise protocols utilised (cycling vs. running). Ultimately, results from the present study 486 
have future implications on scientific study designs. Those wishing to investigate cold 487 
induced post-exercise responses in skeletal muscle must be aware of the evidence that 488 
implicates a systemic response of Normetanephrine, and a local response of p-AMPK in both 489 
immersed and non-immersed limbs. Further evidence is required to support the impact of 490 
systemic transcriptional responses in unilateral research designs, as such designs may be 491 
liable to error; potentially underestimating the actual response occurring in the immersed 492 
limb if relativized to a non-immersed limb instead of a resting control. Ultimately, the choice 493 
of scientific design lies with the question posed, as contralateral designs remain useful for 494 
understanding both local and systemic responses.  495 
In summary, the present study characterises for the first time the mechanistic control of cold 496 
induced PGC-1α mRNA expression. Data herein indicate a reduction in tissue temperature 497 
(2-3°C) plays a limited role as similar levels of PGC-1α mRNA expression are observed in an 498 
immersed and non-immersed limb despite a reduction in tissue temperature in the CWI limb 499 
only. Moreover, a cold-induced systemic increase in plasma Normetanephrine may impact 500 
localised phosphorylation events of the signalling kinase AMPKThr172, with potential 501 
downstream effects upon rates of PGC-1α mRNA expression. Future studies should 502 
investigate the role of β-adrenergic receptors in Normetanephrine induced AMPK 503 
phosphorylation and the signalling role of MEF2 and CRE/ATF2 sites to confirm a link 504 
between catecholamines and PGC-1α. Moreover, due to the acute nature of the present study 505 
more work is required to investigate whether the response seen herein is maintained over a 506 
more chronic term.  507 
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Table 1: Primer sequences used for real-time PCR. 6 
Gene Forward Primer Reverse Primer Product Length 
(base pairs) 
GAPDH 
NM_002046.5 
AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 168 
PGC-1alpha 
NM_013261.3 
TGCTAAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 67 
p53 
NM_000546.5 
ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 141 
SIRT1 
NM_012238.4 
CGGAAACAATACCTCCACCT CACATGAAACAGACACCCCA 186  
COXIV 
NM_001861.4 
CGAGCAATTTCCACCTCTGT  GGTCACGCCGATCCATATAA 94 
CS 
NM_004077.2 
CCTGCCTAATGACCCCATGTT CATAATACTGGAGCAGCACCCC 137 
TFAM 
NM_003201.2 
TGGCAAGTTGTCCAAAGAAACCT
GT 
 
 
GTTCCCTCCAACGCTGGGCA 135 
NRF2 
NM_002040.3 
AAATTGAGATTGATGGAACAGAGAA 
  
TATGGCCTGGCTTACACATTCA 95 
ERRα 
NM_004451.4 
TGCCAATTCAGACTCTGTGC 
  
CCAGCTTCACCCCATAGAAA 212 
 7 
 8 
Table 2: Heart rate and oxygen uptake during immersion and the post-immersion period (n=10, mean ± SD).  9 
  Immersion  Post-Immersion  
PreIm 2min 4min 6min 8min 10min  2min 4min 6min 8min 10min 1hr 2hr 3hr 
HR 
(beats.
min-1)    
CON 88  
±10 
86#     
±9 
86 
±10 
86  
±9 
87  
±8 
86     
±9 
 85#   
±9 
85#   
±9 
84#   
±9 
83#   
±9 
85#  
±10 
85#  
±10 
76#  
±11 
76#  
±10 
 CWI 103 
±14 
117# 
±18 
109 
±16 
104 
±13 
102  
±14 
101 
±13 
 90# 
±13 
90# 
±12 
89# 
±12 
88# 
±11 
88# 
±11 
89# 
±11 
75# 
±13 
73# 
±14 
                 
V̇O2 
(ml/kg
,min-1) 
    
CON 4.6 
±0.9 
4.2 
±0.8 
4.3 
±0.7 
4.4 
±0.8 
4.3 
±0.6 
4.3 
±0.9 
 4.4# 
±0.8 
4.5# 
±0.8 
4.3# 
±0.8 
4.2# 
±0.7 
4.3# 
±0.9 
4.5# 
±0.8 
4.3# 
±0.6 
4.0# 
±0.6 
 CWI 7.05 
±1.4 
8.1 
±1.4 
6.5 
±1.2 
6.3 
±0.7 
6.0 
±1.0 
5.9 
±0.6 
 5.2# 
±1.4 
4.8# 
±1.0 
4.7# 
±0.8 
4.4# 
±0.9 
4.1# 
±1.2 
4.3# 
±1.3 
3.8# 
±0.5 
3.8# 
±0.5 
Values are mean ± SD. A main effect for condition and time along with a significant interaction between condition and time were found for HR and V̇O2 (P < 0.05).  10 
# Significant difference from pre-immersion (P < 0.05).  11 
 12 
 13 
 14 
 15 
Table 3: Catecholamine concentrations (pmol/L) pre and post exercise, with and without 16 
CWI (n=10, mean ± SD). 17 
   Recovery 
Baseline Post-
Exercise 
 Post-
Immersion 
1hr 2hr 3hr 
Normetanephrine CON 326.7  
±165.6 
1711.9# 
±411.10 
 665# 
±291.8 
615.7#  
±368.3 
489.3 
±407.0 
426.9 
±260.0 
 CWI 478.2* 
±189.2 
1774.1*# 
±358.4 
 859.8*# 
±264.5 
716.8*# 
±257.3 
621.2* 
±247.5 
517.2* 
±191.0 
         
Metanephrine CON 199.7 
±62.0 
489.2# 
±234.4 
 231.4# 
±90.5 
193.4 
±75.2 
167.9# 
±62.1 
145.8# 
±68.4 
 
 
CWI 201.6 
±36.7 
509.6# 
±153.9 
 281.8# 
±104.8 
245.6 
±78.3 
176.5#???
?±43.9 
157.5# 
±46.4 
Values are mean ± SD. A main effect for condition was found for NorMetanephrine (P = 0.034). A main effect for time was found for both 18 
NorMetanephrine and Metanephrine (P < 0.001). # Significant difference from baseline (P < 0 .05). *Significant difference versus the CON 19 
condition (P < 0 .05).  20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
28 
Figure 1: Temperature response post-exercise for thigh skin (a) and deep muscle (3cm depth) 29 
(b) with/without CWI. Values are mean ± SD. A main effect for time, condition and time*condition interaction was found in 30 
both thigh and muscle temperature measures (P<0.05). *Significantly different from pre-immersion (Skin) or post-exercise (muscle) (P < 31 
0.05). # Significantly different from CON and NOT (P < 0.05). 32 
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 34 
 35 
Figure 2: Phosphorylation of AMPKThr172 fold changes from Pre, expressed relative to total 36 
AMPK as total AMPK did not change significantly across blots or samples (P > 0.05). Values 37 
are mean ± SD. $ Significant time*condition interaction (P = 0.031).  38 
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 39 
Figure 3: Phosphorylation of p38MAPKThr180/Tyr182 fold change from Pre, expressed relative 40 
to total p38MAPK as total p38 MAPK did not change significantly across blots or samples (P 41 
> 0.05). Values are mean ± SD.   42 
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Figure 4: PGC-1α mRNA (A) and protein content (B) 2-ΔΔCT fold change in expression with 44
the calibrator as pre-exercise and the reference gene as GAPDH (see methods for details). 45
Values are mean ± SD. A main effect for condition and time was found (P < 0.001). There was also a significant interaction between 46
condition and time (P = 0.001) *Significantly different from baseline (P < 0.05). # Significantly different from CON (P < 0.05).   47
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 48 
Figure 5: Representative Western Blots from the control (CON) non-immersed (NOT) and 49 
immersed (CWI) legs before (Pre), after (Post), and 3h after (3h) exercise. p-, phosphorylated; 50 
t-, total. Phosphorylated AMPK Thr172 and p38 MAPK Thr180/Tyr182 were relativized to 51 
their total counterpart, as these did not change significantly across blots or samples (P > 0.05). 52 
PGC-1α was relativized to GAPDH.  53 
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